These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 27812292)

  • 1. Artificial Blood Substitutes: First Steps on the Long Route to Clinical Utility.
    Moradi S; Jahanian-Najafabadi A; Roudkenar MH
    Clin Med Insights Blood Disord; 2016; 9():33-41. PubMed ID: 27812292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Induced Pluripotent Stem Cell Technology in Blood Banking.
    Focosi D; Pistello M
    Stem Cells Transl Med; 2016 Mar; 5(3):269-74. PubMed ID: 26819256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toward 21st century blood component replacement therapeutics: artificial oxygen carriers, platelet substitutes, recombinant clotting factors, and others.
    Kim HW; Greenburg AG
    Artif Cells Blood Substit Immobil Biotechnol; 2006; 34(6):537-50. PubMed ID: 17090427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution of artificial cells using nanobiotechnology of hemoglobin based RBC blood substitute as an example.
    Chang TM
    Artif Cells Blood Substit Immobil Biotechnol; 2006; 34(6):551-66. PubMed ID: 17090428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Artificial blood: the future of blood transfusion? II. Blood substitutes other than hemoglobin solutions].
    Guyot M; Doutremepuich C
    J Pharm Belg; 1990; 45(3):196-206. PubMed ID: 2205716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New transfusion strategies: red cell substitutes.
    Winslow RM
    Annu Rev Med; 1999; 50():337-53. PubMed ID: 10073282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent and prominent examples of nano- and microarchitectures as hemoglobin-based oxygen carriers.
    Jansman MMT; Hosta-Rigau L
    Adv Colloid Interface Sci; 2018 Oct; 260():65-84. PubMed ID: 30177214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recent progress and trend in the development of artificial blood].
    Tsuchida E
    Nihon Rinsho; 1994 Sep; 52(9):2483-91. PubMed ID: 7967100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Artificial blood].
    Kobayashi K
    Nihon Geka Gakkai Zasshi; 2005 Jan; 106(1):31-7. PubMed ID: 15696696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Artificial blood in 1990: from a lifelong dream to today's reality].
    Vigneron C
    Bull Acad Natl Med; 1990 Oct; 174(7):947-57; discussion 957-8. PubMed ID: 2081328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The status of hemoglobin-based red cell substitutes.
    Rabinovici R
    Isr Med Assoc J; 2001 Sep; 3(9):691-7. PubMed ID: 11574989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Progress in the red cell substitutes (artificial red cells)].
    Tsuchida E
    Rinsho Ketsueki; 1994 May; 35(5):439-45. PubMed ID: 8028190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineering blood cells and proteins as blood substitutes: A short review.
    Kim HW
    Biotechnol Bioprocess Eng; 2007; 12(1):43. PubMed ID: 32218673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doping with artificial oxygen carriers: an update.
    Schumacher YO; Ashenden M
    Sports Med; 2004; 34(3):141-50. PubMed ID: 14987124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The development of hemoglobin solutions as red cell substitutes.
    Ogden JE; Parry ES
    Int Anesthesiol Clin; 1995; 33(1):115-29. PubMed ID: 7635553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Development and challenge of modified hemoglobins as red blood cell substitutes].
    Lu XL
    Sheng Wu Gong Cheng Xue Bao; 2006 Jan; 22(1):7-18. PubMed ID: 16572834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perfluorochemical-based artificial oxygen carrying red cell substitutes.
    Lane TA
    Transfus Sci; 1995 Mar; 16(1):19-31. PubMed ID: 10155703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modified hemoglobin blood substitutes: present status and future perspectives.
    Chang TM
    Biotechnol Annu Rev; 1998; 4():75-112. PubMed ID: 9890139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymer/hemoglobin assemblies: biodegradable oxygen carriers for artificial red blood cells.
    Li T; Jing X; Huang Y
    Macromol Biosci; 2011 Jul; 11(7):865-75. PubMed ID: 21312333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Artificial blood - coming soon or never reaching clinical maturity?].
    Schöler M; Frietsch T; Jambor C; Knels R
    Dtsch Med Wochenschr; 2010 Mar; 135(12):575-81. PubMed ID: 20234994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.